{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:16:37Z","timestamp":1791314197755,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clbc.2023.05.008","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T17:37:05Z","timestamp":1684690625000},"page":"649-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Active Surveillance of Atypical Ductal Hyperplasia of the Breast"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1050-7679","authenticated-orcid":false,"given":"Lynn K.","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dodelzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula S.","family":"Ginter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Towne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clbc.2023.05.008_bib0001","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jamainternmed.2015.3043","article-title":"Breast cancer screening, incidence, and mortality across US counties","volume":"175","author":"Harding","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.008_bib0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13058-018-0967-1","article-title":"Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape","volume":"20","author":"Kader","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.clbc.2023.05.008_bib0003","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2023.05.008_bib0004","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12885-017-3808-1","article-title":"Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis","volume":"17","author":"Thomas","year":"2017","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.clbc.2023.05.008_bib0005","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","article-title":"Using autopsy series to estimate the disease \u201creservoir\u201d for ductal carcinoma in situ of the breast: How much more breast cancer can we find?","volume":"127","author":"Welch","year":"1997","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.clbc.2023.05.008_bib0006","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1987.296","article-title":"Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies","volume":"56","author":"Nielsen","year":"1987","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.008_bib0007","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.humpath.2013.08.010","article-title":"Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer","volume":"45","author":"Li","year":"2014","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.008_bib0008","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-017-4253-1","article-title":"Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia","volume":"164","author":"Pe\u00f1a","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.008_bib0009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjsurg.2013.05.014","article-title":"Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium","volume":"207","author":"Menes","year":"2014","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.008_bib0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.breast.2010.06.004","article-title":"Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy","volume":"20","author":"Deshaies","year":"2011","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.clbc.2023.05.008_bib0011","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1245\/s10434-020-08881-0","article-title":"Development and prospective validation of a risk calculator that predicts a low risk cohort for atypical ductal hyperplasia upstaging to malignancy: evidence for a watch and wait strategy of a high-risk lesion","volume":"27","author":"Lustig","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.008_bib0012","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2019190748","article-title":"Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: systematic review and meta-analysis of 6458 lesions","volume":"294","author":"Schiaffino","year":"2020","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.008_bib0013","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.amjsurg.2007.07.038","article-title":"Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? a retrospective study of 300 patients","volume":"196","author":"Forgeard","year":"2008","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.008_bib0014","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1245\/s10434-010-1127-8","article-title":"Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision","volume":"18","author":"Nguyen","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.05.008_bib0015","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1245\/s10434-012-2575-0","article-title":"Atypical ductal hyperplasia on core biopsy: An automatic trigger for excisional biopsy?","volume":"19","author":"McGhan","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.008_bib0016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1309\/0GYV4F2LLJAV4GFN","article-title":"Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision","volume":"119","author":"Sneige","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clbc.2023.05.008_bib0017","unstructured":"The American Society of Breast Surgeons. Consensus guideline on concordance assessment of image-guided breast biopsies and management of borderline or high-risk lesions. 2016. Available at: https:\/\/www.breastsurgeons.org\/docs\/statements\/Consensus-Guideline-on-Concordance-Assessment-of-Image-Guided-Breast-Biopsies.pdf. Accessed January 18, 2022."},{"issue":"6","key":"10.1016\/j.clbc.2023.05.008_bib0018","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1097\/SLA.0000000000004849","article-title":"Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision","volume":"276","author":"Kilgore","year":"2021","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.008_bib0019","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1245\/s10434-016-5512-9","article-title":"Long-term safety of observation in selected women following core biopsy diagnosis of atypical ductal hyperplasia","volume":"24","author":"Menen","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.008_bib0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11547-011-0626-9","article-title":"Vacuum-assisted biopsy diagnosis of atypical ductal hyperplasia and patient management","volume":"116","author":"Ancona","year":"2011","journal-title":"Radiol Med"},{"key":"10.1016\/j.clbc.2023.05.008_bib0021","series-title":"WHO Classification of Breast Tumours","first-page":"18","article-title":"Atypical ductal hyperplasia","author":"Allison","year":"2019"},{"key":"10.1016\/j.clbc.2023.05.008_bib0022","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0221-0363(04)97598-1","article-title":"\u201c[Underestimation of breast carcinoma with 11-gauge stereotactically guided directional vacuum-assisted biopsy].\u201d","volume":"85","author":"Plantade","year":"2004","journal-title":"J radiol"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.008_bib0023","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2214\/AJR.11.6588","article-title":"Atypical ductal hyperplasia diagnosed at 11-gauge vacuum-assisted breast biopsy performed on suspicious clustered microcalcifications: could patients without residual microcalcifications be managed conservatively?","volume":"197","author":"Villa","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2023.05.008_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2017.10.003","article-title":"Atypical ductal hyperplasia: our experience in the management and long term clinical follow-up in 71 patients","volume":"37","author":"Latronico","year":"2018","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.clbc.2023.05.008_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.clbc.2023.05.008_bib0026","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2023.05.008_bib0027","unstructured":"The Low Risk DCIS Trial (LORIS). A phase III trial of surgery versus active monitoring for low-risk ductal carcinoma in situ (DCIS). 2016. Available at: https:\/\/www.birmingham.ac.uk\/Documents\/college-mds\/trials\/crctu\/Loris\/LORIS-Trial-Protocol-Vn4.0-15.03.16.pdf. Accessed March 21, 2022."},{"key":"10.1016\/j.clbc.2023.05.008_bib0028","unstructured":"U.S. National Library of Medicine. Management of low-risk (Grade I and II) DCIS (LORD). 2015. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02492607. Accessed March 21, 2022."},{"issue":"1","key":"10.1016\/j.clbc.2023.05.008_bib0029","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ajcp\/aqz143","article-title":"Atypical ductal hyperplasia and those bordering on ductal carcinoma in situ should be included in the active surveillance clinical trials","volume":"153","author":"Khoury","year":"2020","journal-title":"Am J Clin Pathol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:34Z","timestamp":1761513934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923001301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1526820923001301"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.008","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active Surveillance of Atypical Ductal Hyperplasia of the Breast","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}